Institutional investors hold a majority ownership of AGN through the 84.09% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2016, these large investors purchased a net $11.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 3.2 Million shares of Allergan
LAZARD ASSET MANAGEMENT LLC Bought 1.1 Million shares of Allergan
JENNISON ASSOCIATES LLC Bought 878.7 Thousand shares of Allergan